These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34469777)

  • 1. Generation of a homozygous LRPAP1 knockout human embryonic stem cell line (FDCHDPe009-B) by CRISPR/Cas9 system.
    You J; Xi H; Ma S; Yang XJ; Chen L
    Stem Cell Res; 2021 Oct; 56():102516. PubMed ID: 34469777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a homozygous P4HA2 knockout human embryonic stem cell line (FDCHDPe012-A) by CRISPR/Cas9 system.
    You J; Ma S; Zhang H; Chen L
    Stem Cell Res; 2022 Oct; 64():102930. PubMed ID: 36206672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing.
    Getachew A; Yang Z; Huang X; Wu F; Liu YY; Yan C; Yang F; Li Y
    Stem Cell Res; 2021 Jul; 54():102401. PubMed ID: 34058685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a DKK1 homozygous knockout human embryonic stem cell line WAe001-A-21 using CRISPR/Cas9.
    Yang Z; Yuan F; Wang N; Liu Y; Zhang J; Wei R; Wu F; Wu Y; You K; Chen Y; Yang F; Li YX
    Stem Cell Res; 2021 Mar; 51():102161. PubMed ID: 33461039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generating dHAND homozygous knockout human embryonic stem cell line (WAe009-A-59) by episomal vector-based CRISPR/Cas9 system.
    Wang W; Bai R; Song X
    Stem Cell Res; 2021 Aug; 55():102471. PubMed ID: 34332328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a KCNQ1 homozygous knockout human embryonic stem cell line by episomal vector-based CRISPR/Cas9 system.
    Liu X; Zhang S; Chang Y; Wu F; Bai R
    Stem Cell Res; 2021 Aug; 55():102467. PubMed ID: 34343827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system.
    Wu F; Li X; Bai R; Li Y; Gao J; Lan F
    Stem Cell Res; 2020 Oct; 48():101930. PubMed ID: 32777767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a homozygous ALX1 knockout human embryonic stem cell line (WAe001-A-060) by a CRISPR/Cas9 system.
    Xiao X; Chen Y; Peng L; Zhang T
    Stem Cell Res; 2021 May; 53():102309. PubMed ID: 33799274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system.
    Dong T; Zhang S; Chang Y; Bai R; Jiang Y; Ma S; Li Y; Jiang HF; Lu WJ
    Stem Cell Res; 2021 Mar; 51():102196. PubMed ID: 33524674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a TPM1 homozygous knockout embryonic stem cell line by CRISPR/Cas9 editing.
    Ma S; Xu Q; Bai R; Dong T; Peng Z; Liu X
    Stem Cell Res; 2021 Aug; 55():102470. PubMed ID: 34352617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9.
    Yuan F; Guo D; Gao G; Liu Y; Xu Y; Wu Y; Yang F; Ke X; Lai K; Hong L; Li YX
    Stem Cell Res; 2017 Oct; 24():89-93. PubMed ID: 29034901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a SMO homozygous knockout human embryonic stem cell line WAe001-A-16 by CRISPR/Cas9 editing.
    Wu F; Gao G; Pan T; Yang Z; Xu G; Abbas N; Liu Y; Chen Y; Tan S; You K; Ke X; Zhuang Y; Lin X; Yang F; Li YX
    Stem Cell Res; 2018 Mar; 27():5-9. PubMed ID: 29278761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a MCPH1 knockout human embryonic stem cell line by CRISPR/Cas9 technology.
    Wang Z; Cui Y; Shan Y; Kang B; Shi L; Geng K; Han J
    Stem Cell Res; 2020 Dec; 49():102105. PubMed ID: 33370873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.
    Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
    Stem Cell Res; 2017 Mar; 19():46-48. PubMed ID: 28413005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9.
    Lu F; Gao Y; Li E
    Stem Cell Res; 2023 Sep; 71():103162. PubMed ID: 37429070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an S100B homozygous knockout pluripotent stem cell line (WAe009-A-94) by the CRISPR/Cas9 system.
    Zhang P; Wang H; Li S; Guo T; Zhang R; Zhou P; Ding S
    Stem Cell Res; 2022 Oct; 64():102924. PubMed ID: 36182708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an NSD2-deficient human embryonic stem cell line using CRISPR/Cas9 technology.
    Zhao K; Zhang H; Cui J; Zhang Y; Zhou T; Long B
    Stem Cell Res; 2023 Dec; 73():103255. PubMed ID: 37992565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9.
    Yuan F; Guo D; Liu Y; Xu Y; Gao G; Wu Y; Yang F; Ke X; Lai K; Wei H; Li YX
    Stem Cell Res; 2018 Jan; 26():67-71. PubMed ID: 29247816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a human TLR4 compound heterozygous knockout hESC line (WAe009-A-N) to model toll-like receptor 4 deficiency by CRISPR/Cas9 system.
    Ruan Y; Tian X; Li X; Zhang Y
    Stem Cell Res; 2023 Dec; 73():103225. PubMed ID: 37931537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.
    Qin Z; Sun L; Sun X; Su H; Gao X
    Stem Cell Res; 2021 Oct; 56():102562. PubMed ID: 34634758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.